{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:01:31Z","timestamp":1793246491970,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":62,"publisher":"Springer New York","isbn-type":[{"value":"9781441964472","type":"print"},{"value":"9781441964489","type":"electronic"}],"license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-4419-6448-9_6","type":"book-chapter","created":{"date-parts":[[2011,1,9]],"date-time":"2011-01-09T06:57:34Z","timestamp":1294556254000},"page":"64-74","source":"Crossref","is-referenced-by-count":31,"title":["Clinical Features and Molecular Mechanisms of Spinal and Bulbar Muscular Atrophy (SBMA)"],"prefix":"10.1007","author":[{"given":"Masahisa","family":"Katsuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1023\/A:1005344403603","volume":"20","author":"K.H. Fischbeck","year":"1997","unstructured":"Fischbeck KH. Kennedy disease. J Inherit Metab Dis 1997; 20:152\u2013158.","journal-title":"J Inherit Metab Dis"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.18.7.671","volume":"18","author":"W.R. Kennedy","year":"1968","unstructured":"Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 1968; 18:671\u2013680.","journal-title":"Neurology"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2006.01.021","volume":"200","author":"M. Katsuno","year":"2006","unstructured":"Katsuno M, Adachi H, Waza M et al. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Exp Neurol 2006; 200:8\u201318.","journal-title":"Exp Neurol"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.clinph.2006.10.006","volume":"118","author":"C. Pachatz","year":"2007","unstructured":"Pachatz C, Terracciano C, Desiato MT et al. Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy. Clin Neurophysiol 2007; 118:262\u2013268.","journal-title":"Clin Neurophysiol"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/brain\/awl096","volume":"129","author":"N. Atsuta","year":"2006","unstructured":"Atsuta N, Watanabe H, Ito M et al. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 2006; 129:1446\u20131455.","journal-title":"Brain"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/mus.21077","volume":"38","author":"Y. Takeuchi","year":"2008","unstructured":"Takeuchi Y, Katsuno M, Banno H et al. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 2008; 38:964\u2013971.","journal-title":"Muscle Nerve"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/01.WNL.0000151978.74467.E7","volume":"64","author":"A.D. Sperfeld","year":"2005","unstructured":"Sperfeld AD, Hanemann CO, Ludolph AC et al. Laryngospasm: an underdiagnosed symptom of X-linked spinobulbar muscular atrophy. Neurology 2005; 64:753\u2013754.","journal-title":"Neurology"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/brain\/awm289","volume":"131","author":"K. Suzuki","year":"2008","unstructured":"Suzuki K, Katsuno M, Banno H et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 2008; 131:229\u2013239.","journal-title":"Brain"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1468-1331.2008.02349.x","volume":"16","author":"K. Inoue","year":"2009","unstructured":"Inoue K, Hemmi S, Miyaishi M et al. Muscular fatigue and decremental response to repetitive nerve stimulation in X-linked spinobulbar muscular atrophy. Eur J Neurol 2009; 16:76\u201380.","journal-title":"Eur J Neurol"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1210\/jc.87.8.3893","volume":"87","author":"S. Dejager","year":"2002","unstructured":"Dejager S, Bry-Gauillard H, Bruckert E et al. A comprehensive endocrine description of Kennedy\u2019s disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocr Metab 2002; 87:3893\u20133901.","journal-title":"J Clin Endocr Metab"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0022-510X(93)90157-T","volume":"117","author":"G. Sobue","year":"1993","unstructured":"Sobue G, Doyu M, Kachi T et al. Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy. J Neurol Sci 1993; 117:74\u201378.","journal-title":"J Neurol Sci"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"A.R. Spada La","year":"1991","unstructured":"La Spada AR, Wilson EM, Lubahn DB et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352:77\u201379.","journal-title":"Nature"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/hmg\/6.12.2005","volume":"6","author":"S.E. Andrew","year":"1997","unstructured":"Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 1997; 6:2005\u20132010.","journal-title":"Hum Mol Genet"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrg1691","volume":"6","author":"J.R. Gatchel","year":"2005","unstructured":"Gatchel JR, Zoghbi HY. Diseases of unstable repeat expansion: mechanism and principles. Nat Rev Genet 2005; 6:743\u2013755.","journal-title":"Nat Rev Genet"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/hmg\/5.9.1253","volume":"5","author":"F. Tanaka","year":"1996","unstructured":"Tanaka F, Doyu M, Ito Y et al. Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum Mol Genet 1996; 5:1253\u20131257.","journal-title":"Hum Mol Genet"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/ana.410320517","volume":"32","author":"M. Doyu","year":"1992","unstructured":"Doyu M, Sobue G, Mukai E et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 1992; 32:707\u2013710.","journal-title":"Ann Neurol"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jsbmb.2007.09.016","volume":"108","author":"I. Palazzolo","year":"2008","unstructured":"Palazzolo I, Gliozzi A, Rusmini P et al. The role of the polyglutamine tract in androgen receptor. J Steroid Biochem Mol Biol 2008; 108:245\u2013253.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G. Sobue","year":"1989","unstructured":"Sobue G, Hashizume Y, Mukai E et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 1989; 112:209\u2013232.","journal-title":"Brain"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.410440216","volume":"44","author":"M. Li","year":"1998","unstructured":"Li M, Miwa S, Kobayashi Y et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 1998; 44:249\u2013254.","journal-title":"Ann Neurol"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M. Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004; 431:805\u2013810.","journal-title":"Nature"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nsmb1215","volume":"14","author":"Y. Nagai","year":"2007","unstructured":"Nagai Y, Inui T, Popiel HA et al. A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol 2007; 14:332\u2013340.","journal-title":"Nat Struct Mol Biol"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/brain\/awh381","volume":"128","author":"H. Adachi","year":"2005","unstructured":"Adachi H, Katsuno M, Minamiyama M et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 2005; 128:659\u2013670.","journal-title":"Brain"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.20735","volume":"59","author":"H. Banno","year":"2006","unstructured":"Banno H, Adachi H, Katsuno M et al. Mutant androgen receptor accumulation in SBMA scrotal skin: a pathogenic marker. Ann Neurol 2006; 59:520\u2013526.","journal-title":"Ann Neurol"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yfrne.2004.03.001","volume":"25","author":"A. Poletti","year":"2004","unstructured":"Poletti A. The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons. Front. Neuroendocrinol 2004; 25:1\u201326.","journal-title":"Neuroendocrinol"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/hmg\/10.10.1039","volume":"10","author":"H. Adachi","year":"2001","unstructured":"Adachi H, Kume A, Li M et al. Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum Mol Genet 2001; 10:1039\u20131048.","journal-title":"Hum Mol Genet"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1385\/JMN:23:1-2:069","volume":"23","author":"A. Wyttenbach","year":"2004","unstructured":"Wyttenbach A. Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis. J Mol Neurosci 2004; 23:69\u201396.","journal-title":"J Mol Neurosci"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrn1587","volume":"6","author":"P.J. Muchowski","year":"2005","unstructured":"Muchowski PJ, Wacker JL. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 2005; 6:11\u201322.","journal-title":"Nat Rev Neurosci"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1074\/jbc.M609972200","volume":"282","author":"M. Li","year":"2007","unstructured":"Li M, Chevalier-Larsen ES, Merry DE et al. Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J Biol Chem 2007; 282:3157\u20133164.","journal-title":"J Biol Chem"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M. Katsuno","year":"2002","unstructured":"Katsuno M, Adachi H, Kume A et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 2002; 35:843\u2013854.","journal-title":"Neuron"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2353\/ajpath.2006.050619","volume":"168","author":"Z. Yu","year":"2006","unstructured":"Yu Z, Dadgar N, Albertelli M et al. Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am J Pathol 2006; 168:195\u2013204.","journal-title":"Am J Pathol"},{"key":"6_CR31","doi-asserted-by":"crossref","unstructured":"Montie HL, Cho MS, Holder L et al. Cytoplasmic Retention of Polyglutamine-Expanded Androgen Receptor Ameliorates Disease via Autophagy in a Mouse Model of Spinal and Bulbar Muscular Atrophy. Hum Mol Genet 2009 (Epub ahead of print).","DOI":"10.1093\/hmg\/ddp115"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","volume":"35","author":"K. Takeyama","year":"2002","unstructured":"Takeyama K, Ito S, Yamamoto A et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 2002; 35:855\u2013864.","journal-title":"Neuron"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","volume":"24","author":"E.S. Chevalier-Larsen","year":"2004","unstructured":"Chevalier-Larsen ES, O\u2019Brien CJ, Wang H et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 2004; 24:4778\u20134786.","journal-title":"J Neurosci"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1523\/JNEUROSCI.3032-06.2006","volume":"26","author":"M. Katsuno","year":"2006","unstructured":"Katsuno M, Adachi H, Minamiyama M et al. Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J Neurosci 2006; 26:12106\u201312117.","journal-title":"J Neurosci"},{"key":"6_CR35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/WNL.59.5.770","volume":"59","author":"B.J. Schmidt","year":"2002","unstructured":"Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ et al. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 2002; 59:770\u2013772.","journal-title":"Neurology"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/jnnp.2006.101899","volume":"79","author":"P. Kinirons","year":"2008","unstructured":"Kinirons P, Rouleau GA. Administration of testosterone results in reversible deterioration in Kennedy\u2019s disease. J Neurol Neurosurg Psychiatry 2008; 79:106\u2013107.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/81814","volume":"3","author":"X. Lin","year":"2000","unstructured":"Lin X, Antalffy B, Kang D et al. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci 2000; 3:157\u2013163.","journal-title":"Nat Neurosci"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R. Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL et al. Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet 2000; 9:1259\u20131271.","journal-title":"Hum Mol Genet"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/hmg\/ddh144","volume":"13","author":"D.G. Hay","year":"2004","unstructured":"Hay DG, Sathasivam K, Tobaben S et al. Progressive decrease in chaperone protein levels in a mouse model of Huntington\u2019s disease and induction of stress proteins as a therapeutic approach. Hum Mol Genet 2004; 13:1389\u20131405.","journal-title":"Hum Mol Genet"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"16801","DOI":"10.1073\/pnas.0506249102","volume":"102","author":"M. Katsuno","year":"2005","unstructured":"Katsuno M, Sang C, Adachi H et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci USA 2005; 102:16801\u201316806.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"F. J. Nucifora","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 2001; 291:2423\u20132428.","journal-title":"Science"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"J.S. Steffan","year":"2001","unstructured":"Steffan JS, Bodai L, Pallos J et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001; 413:739\u2013743.","journal-title":"Nature"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","volume":"13","author":"M. Minamiyama","year":"2004","unstructured":"Minamiyama M, Katsuno M, Adachi H et al. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 2004; 13:1183\u20131192.","journal-title":"Hum Mol Genet"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0896-6273(04)00082-0","volume":"41","author":"B.L. Sopher","year":"2004","unstructured":"Sopher BL, Thomas PS Jr, LaFevre-Bernt MA et al. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 2004; 41:687\u2013699.","journal-title":"Neuron"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1073\/pnas.0809819106","volume":"106","author":"E. Suzuki","year":"2009","unstructured":"Suzuki E, Zhao Y, Ito S et al. Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity. Proc Natl Acad Sci USA 2009; 106:3818\u20133822.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ng1123","volume":"33","author":"I. Puls","year":"2003","unstructured":"Puls I, Jonnakuty C, LaMonte BH et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33:455\u2013456.","journal-title":"Nat Genet"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.1083129","volume":"300","author":"M. Hafezparast","year":"2003","unstructured":"Hafezparast M, Klocke R, Ruhrberg C et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003; 300:808\u2013812.","journal-title":"Science"},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nn1717","volume":"9","author":"G. Morfini","year":"2006","unstructured":"Morfini G, Pigino G, Szebenyi G et al. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat Neurosci 2006; 9:907\u2013916.","journal-title":"Nat Neurosci"},{"key":"6_CR49","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1523\/JNEUROSCI.4072-08.2009","volume":"29","author":"J.E. Young","year":"2009","unstructured":"Young JE, Garden GA, Martinez RA et al. Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5\/Hrk. J Neurosci 2009; 29:1987\u20131997.","journal-title":"J Neurosci"},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/hmg\/ddn310","volume":"18","author":"S. Ranganathan","year":"2009","unstructured":"Ranganathan S, Harmison GG, Meyertholen K et al. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum Mol Genet 2009; 18:27\u201342.","journal-title":"Hum Mol Genet"},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/nn1750","volume":"9","author":"S.K. Custer","year":"2006","unstructured":"Custer SK, Garden GA, Gill N et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 2006; 9:1302\u20131311.","journal-title":"Nat Neurosci"},{"key":"6_CR52","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1073\/pnas.0705501104","volume":"104","author":"D.A. Monks","year":"2007","unstructured":"Monks DA, Johansen JA, Mo K et al. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci USA 2007; 104:18259\u201318264.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M. Katsuno","year":"2003","unstructured":"Katsuno M, Adachi H, Doyu M et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 2003; 9:768\u2013773.","journal-title":"Nat Med"},{"key":"6_CR54","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ana.21540","volume":"65","author":"H. Banno","year":"2009","unstructured":"Banno H, Katsuno M, Suzuki K et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 2009; 65:140\u2013150.","journal-title":"Ann Neurol"},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nm1547","volume":"13","author":"Z. Yang","year":"2007","unstructured":"Yang Z, Chang YJ, Yu IC et al. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat Med 2007; 13:348\u2013353.","journal-title":"Nat Med"},{"key":"6_CR56","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","volume":"16","author":"I. Palazzolo","year":"2007","unstructured":"Palazzolo I, Burnett BG, Young JE et al. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet 2007; 16:1593\u20131603.","journal-title":"Hum Mol Genet"},{"key":"6_CR57","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/hmg\/ddn419","volume":"18","author":"K. Tokui","year":"2009","unstructured":"Tokui K, Adachi H, Waza M et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum Mol Genet 2009; 18:898\u2013910.","journal-title":"Hum Mol Genet"},{"key":"6_CR58","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm1298","volume":"11","author":"M. Waza","year":"2005","unstructured":"Waza M, Adachi H, Katsuno M et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med 2005; 11:1088\u20131095.","journal-title":"Nat Med"},{"key":"6_CR59","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1523\/JNEUROSCI.23-06-02203.2003","volume":"23","author":"H. Adachi","year":"2003","unstructured":"Adachi H, Katsuno M, Minamiyama M et al. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J Neurosci 2003; 23:2203\u20132211.","journal-title":"J Neurosci"},{"key":"6_CR60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/hmg\/11.5.515","volume":"11","author":"C.K. Bailey","year":"2002","unstructured":"Bailey CK, Andriola IF, Kampinga HH et al. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum Mol Genet 2002; 11:515\u2013523.","journal-title":"Hum Mol Genet"},{"key":"6_CR61","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1523\/JNEUROSCI.1242-07.2007","volume":"27","author":"H. Adachi","year":"2007","unstructured":"Adachi H, Waza M, Tokui K et al. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J Neurosci 2007; 27:5115\u20135126.","journal-title":"J Neurosci"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"12580","DOI":"10.1074\/jbc.M511677200","volume":"281","author":"M. Ying","year":"2006","unstructured":"Ying M, Xu R, Wu X et al. Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA. J Biol Chem 2006; 281:12580\u201312586.","journal-title":"J Biol Chem"}],"container-title":["Advances in Experimental Medicine and Biology","Diseases of DNA Repair"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-6448-9_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T14:35:18Z","timestamp":1558103718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-6448-9_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9781441964472","9781441964489"],"references-count":62,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-6448-9_6","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}